Yield10 Bioscience Inc. (YTEN)

$0.02

$0.00 (0.00%)

As on 21-Feb-2025 09:30EDT

Market cap

info icon

$0 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

11.2

Div. Yield

info icon

0 %

Yield10 Bioscience (YTEN) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.02 High: 0.02

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -15.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -0.5

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    692,683

10 Years Aggregate

CFO

$-125.80 Mln

EBITDA

$-130.91 Mln

Net Profit

$-141.61 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Yield10 Bioscience (YTEN)
-96.3 1,400.0 -96.3 -94.6 -84.5 -71.1 -67.3
BSE Sensex*
-8.7 1.6 1.7 -4.3 6.0 6.7 10.8
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 21-Feb-2025  |  *As on 27-Aug-2026  |  #As on 26-Oct-2023
Company
2024
2023
2022
2021
2020
2019
2018
Yield10 Bioscience (YTEN)
66.7 -85.6 -66.1 -14.9 -15.7 -79.3 -52.9
S&P Small-Cap 600
7.0 13.9 -17.4 25.3 9.6 20.9 -9.7
BSE Sensex
8.1 18.7 4.4 22.0 15.8 14.4 5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Yield10 Bioscience (YTEN)
0.0 0.4 0.8 -12.7 -1,153.8 -- -- 11.2
20.0 50.8 2.7 -86.3 -3,195.0 -61.7 -- 0.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Yield10 Bioscience (YTEN)

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty...  acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. 

  • Co-Founder, President, CEO & Director

    Dr. Oliver P. Peoples Ph.D.

  • Co-Founder, President, CEO & Director

    Dr. Oliver P. Peoples Ph.D.

  • Headquarters

    Woburn, MA

  • Website

    https://www.yield10bio.com

FAQs for Yield10 Bioscience (YTEN)

The share price of Yield10 Bioscience Inc (YTEN) is $0.02 (NASDAQ) as of 21-Feb-2025 09:30 EDT. Yield10 Bioscience Inc (YTEN) has given a return of -84.54% in the last 3 years.

Since, TTM earnings of Yield10 Bioscience Inc (YTEN) is negative, P/E ratio is not available.
The P/B ratio of Yield10 Bioscience Inc (YTEN) is 11.23 times as on 21-Feb-2025, a 110 premium to its peers’ median range of 5.35 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2023
--
--
2022
--
--
2021
--
--
2020
--
--
2019
--
--

The 52-week high and low of Yield10 Bioscience Inc (YTEN) are Rs -- and Rs -- as of 27-Aug-2026.

Yield10 Bioscience Inc (YTEN) has a market capitalisation of $ 0 Mln as on 21-Feb-2025. As per SEBI classification, it is a Small Cap company.

Before investing in Yield10 Bioscience Inc (YTEN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...